Study links fructose to increased spread of ovarian cancer
Fructose may promote the spread of aggressive ovarian cancer by weakening cell bonds, according to new preclinical research published in Nature Aging.
Key Takeaways
AIA recent study published in the journal Nature Aging has found that fructose—a sugar naturally present in fruit and honey and widely used in sweetened foods and beverages—may play a role in promoting the spread of aggressive ovarian cancer.
The study showed that some cancer cells surviving chemotherapy secrete fructose, which acts as a signal prompting neighboring cancer cells to detach from the original tumor and migrate to other areas.
Lead researcher Dr. Idan Cohen from Dr. Katherine Aird’s lab at the Wistar Institute explained that some of these cells "no longer divide, but remain biologically active," continuing to release molecules that affect surrounding cells. Among these molecules is fructose, which may serve as a signaling mediator between cancer cells, according to Science Daily.
Most ovarian cancer patients undergo chemotherapy based on platinum compounds that target the DNA of cancer cells and limit their proliferation. However, the disease often recurs, and cancer spread within the abdominal cavity (metastasis) accounts for about 90% of ovarian cancer deaths.
For this reason, researchers are focusing on understanding the mechanisms that allow cancer cells to leave their original site and form new tumors.
The study built on previous observations that cancer cells surviving chemotherapy can contribute to disease recurrence even after they stop dividing. To investigate, researchers designed an experiment separating the surviving cells from the substances they secrete.
Results showed that these secreted substances alone were enough to increase cancer spread in preclinical models. Further analysis revealed that fructose was the main factor driving the spread of cancer cells.
The study indicated that fructose not only provides energy to cells, but may also act as a chemical messenger that enhances the ability of neighboring cancer cells to spread.
Preclinical experiments demonstrated that consuming large amounts of fructose—comparable to levels found in some sugary drinks—could enhance signals linked to cancer spread even in the absence of chemotherapy.
Although these findings have not yet been tested in humans, they open the door to further research on the relationship between high-sugar diets and tumor behavior.
To understand the biological mechanism of fructose’s effect, the team used advanced techniques, including CRISPR-based assays, to study genes associated with the disease. The results showed that fructose suppresses cholesterol production in neighboring cancer cells, weakening the bonds that hold cells together—described by researchers as a kind of "biological glue."
When fructose reduces cholesterol production, these bonds weaken, making it easier for cells to detach and migrate to other parts of the body.
These findings led researchers to examine the effect of statin drugs, which are used to lower cholesterol and prevent heart disease and strokes. Experiments showed that these drugs can also weaken the bonds between cancer cells, potentially facilitating their separation and spread.
However, the researchers emphasized that these results are still limited to preclinical studies and have not yet been tested in humans. They stressed that patients should not stop taking prescribed statins based on these findings until further studies are available.
While the study focused on ovarian cancer, the team suggested that the same biological mechanism could exist in other cancers that spread within the abdomen or trunk, such as pancreatic, colon, and liver cancers, if fructose affects cancer cell cohesion in a similar way.
Thus, the significance of this discovery may extend beyond ovarian cancer, offering broader insights into how various types of tumors spread.
